Hepatitis B - Predicting survival in hepatitis B

被引：19

作者：

Sherman, M

机构：

[1] Univ Toronto, Toronto, ON M5G 2C4, Canada

[2] Toronto Gen Hosp, Univ Hlth Network, Toronto, ON M5G 2C4, Canada

来源：

GUT | 2005年 / 54卷 / 11期

关键词：

D O I：

10.1136/gut.2005.071332

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Alanine aminotransferase (ALT) level alone is not an appropriate indication for therapy in chronic hepatitis B infection, and other criteria in addition to ALT must be used to determine eligibility for therapy.

引用

页码：1521 / 1523

页数：3

共 34 条

[11] THE NATURAL-HISTORY OF ASYMPTOMATIC HEPATITIS-B SURFACE-ANTIGEN CARRIERS
DEFRANCHIS, R
MEUCCI, G
VECCHI, M
TATARELLA, M
COLOMBO, M
DELNINNO, E
RUMI, MG
DONATO, MF
RONCHI, G
[J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (03) : 191 - 194
[12] Evans AA, 2004, HEPATOLOGY, V40, p602A
[13] Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
Hsu, YS
Chien, RN
Yeh, CT
Sheen, IS
Chiou, HY
Chu, CM
Liaw, YF
[J]. HEPATOLOGY, 2002, 35 (06) : 1522 - 1527
[14] Iloeje UH, 2005, J HEPATOL, V42, P179
[15] ILOEJE UH, 2005, J HEPATOL S2, V42, P180
[16] ILOEJE UH, 2005, J HEPATOL SI, V42, P180
[17] Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B
Lai, CL
Dienstag, J
Schiff, E
Leung, NWY
Atkins, M
Hunt, C
Brown, N
Woessner, M
Boehme, R
Condreay, L
[J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 (06) : 687 - 696
[18] Lau G, 2004, HEPATOLOGY, V40, p171A
[19] Asian-Pacific consensus statement on the management of chronic hepatitis B: An update
Liaw, YF
Leung, N
Guan, R
Lau, GKK
Merican, I
[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (03) : 239 - 245
[20] Lamivudine for patients with chronic hepatitis B and advanced liver disease
Liaw, YF
Sung, JJY
Chow, WC
Farrell, G
Lee, CZ
Yuen, H
Tanwandee, T
Tao, QM
Shue, K
Keene, ON
Dixon, JS
Gray, DF
Sabbat, J
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (15) : 1521 - 1531

← 1 2 3 4 →